Skip to content
Screener

Insulet PODD Finite Lived Intangible Assets - Gross

Finite Lived Intangible Assets - Gross at other companies

Abbott logo
AbbottABT
$39.8B+44.2%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$1.24B+131%
AptarGroup logo
AptarGroupATR
$586.4M+8.8%
TOI
TOITOI
$29.77M-7.1%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$801.7M+23.5%
Gross profit$562.6M+24.4%
Operating income$129.7M+7.1%
Net income$95.0M+322%
EPS (diluted)$1.37+328%

Balance sheet

See full
Cash & equivalents$534.9M-52.3%
Total debt$974.7M-47.6%
Total equity$1.4B-2.8%
Total assets$3.2B-8.8%

Cash flow

See full
Operating cash flow$88.4M-55.0%
CapEx$32.5M+74.7%
Free cash flow$55.9M-68.6%

Valuation

See full
Market cap$9.23B-52.7%
Enterprise value$9.67B-52.3%
P/E24.6×-58.1×
P/S-5.2×

Profitability

See full
Gross margin71.1%+0.3pp
Operating margin16.9%-0.4pp
Net margin12.3%+2.3pp
FCF margin9.6%-7.5pp

Returns & leverage

See full
Return on equity26%+6.8pp
Debt / equity0.7×-0.6×
Current ratio2.5×+0.2×

Where this comes from

Reported directly by Insulet in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The source filing: Insulet’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001145197-26-000169
(in millions)June 30, 2026 / Gross Carrying AmountJune 30, 2026 / Accumulated AmortizationJune 30, 2026 / Net Book ValueDecember 31, 2025 / Gross Carrying AmountDecember 31, 2025 / Accumulated AmortizationDecember 31, 2025 / Net Book Value
Customer relationships$43.1$(36.7)$6.4$43.2$(35.8)$7.4
Internal-use software76.2(20.1)56.168.3(14.1)54.2
Developed technology28.3(8.0)20.328.3(6.9)21.4
Patents44.0(11.8)32.244.0(9.9)34.2
Total intangible assets$191.6$(76.5)$115.1$183.8$(66.7)$117.1

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Insulet's finite lived intangible assets - gross?
Insulet (PODD) reported finite lived intangible assets - gross of $191.6M in Q2 2026.
How has Insulet's finite lived intangible assets - gross changed year-over-year?
Insulet's finite lived intangible assets - gross increased by 17.2% year-over-year, from $163.5M to $191.6M.
What is the long-term trend for Insulet's finite lived intangible assets - gross?
Over 5 years (2020 to 2025), Insulet's finite lived intangible assets - gross has grown at a 26.9% compound annual growth rate (CAGR), from $55.8M to $183.8M.
What does finite lived intangible assets - gross mean?
This metric tracks the total historical cost of intangible assets that have a defined useful life, such as patents, software licenses, or customer relationships. It excludes assets with indefinite lives like certain trademarks or goodwill. It is a key indicator of the company's investment in intellectual property and intangible competitive advantages.

Ask your AI about Insulet's finite lived intangible assets - gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude